Monday, 17 September 2012

Threshold Pharma cancer drug fails to meet study secondary goal

(Reuters) - An experimental pancreatic cancer treatment from Threshold Pharmaceuticals Inc failed to statistically improve the overall survival of patients, sending the company's shares down nearly 33 percent in early trading. The drugmaker sa...

Source: http://health.yahoo.net/news/s/nm/threshold-pharma-cancer-drug-fails-to-meet-study-secondary-goal

UBS AG Netflix Scarlett Johansson Medal of Honor

No comments:

Post a Comment

Note: only a member of this blog may post a comment.